|
1. On 18 August 2004, Yuriy Bilonog (hereinafter the “Athlete”)
participated in the Men’s Shot Put event at the Games of the XXVIII
Olympiad in Athens (the “2004 Olympic Games”), where he placed first and
obtained the gold medal.
2. After this competition, he was requested to provide a urine sample for a doping control.
3.
The A sample of the Athlete was tested during the 2004 Olympic Games
by the WADA Accredited Laboratory in Athens, but the analysis did not
result in an adverse analytical finding at that time.
4. In
January 2005, the A and B samples collected from the Athlete were sent
to the WADA Accredited “Laboratoire Anti-Dopage de Lausanne” (“LAD”),
along with all the other samples collected upon the occasion of the 2004
Olympic Games.
5. In 2012, the IOC decided to perform further
analyses on certain samples collected during the 2004 Olympic Games.
These additional analyses were performed with analytical methods which
were not available in 2004.
6. Pursuant to Article 7.2.1 of the
IOC Anti-Doping Rules applicable to the Games of the XXVIII Olympiad in
Athens in 2004 (the “Rules”), the representative of the Chairman of the
IOC Medical Commission, Dr. Patrick Schamasch, was informed on 13 July
2012 by LAD of the adverse analytical finding on the A sample of the
Athlete.
7. The analytical report indicated the presence of oxandrolone metabolite (an anabolic androgenic steroid).
8.
Pursuant to Article 7.2.2 of the Rules, the IOC Medical Commission
determined that the above-noted A sample belonged to the Athlete, and
verified that it did in fact give rise to an adverse analytical finding.
It was also determined that there was no apparent departure from the
International Standards for Testing or the International Standards for
Laboratories, which would undermine the validity of the adverse
analytical finding.
9. The IOC Medical Commission determined that
the B sample analysis would be conducted on a split B sample basis, with
both parts of the B sample being analysed.
10. Pursuant to
Article 7.2.3 of the Rules, the IOC President, Dr. Jacques Rogge, was
informed of the existence of the adverse analytical finding and the
essential details available concerning the case.
11. Pursuant to Article 7.2.4 of the Rules, the IOC President set up a Disciplinary Commission.
|